Spys Make Asymmetric Chromatin

by Karthik Eswara, Wolfgang Fischle
Year: 2022 DOI: 10.1021/acscentsci.2c00086

Abstract

Molecular processes that occur on symmetric substrates can theoretically produce symmetric or asymmetric outcomes. When nonrandom but controlled and directed, symmetry vs asymmetry can establish complexity and signaling potential. Biological processes often take advantage of discriminating symmetry vs asymmetry, and studying such processes requires molecular and chemical methods that capture the complexity of the natural systems. In this issue of ACS Central Science, Muir and co-workers describe an advanced strategy for making asymmetric chromatin in the test tube. (1)

Chromatin refers to the complex of DNA and histone proteins that serves as the substrate of all genomic (i.e., based on and affecting the genome) processes in a cell. It is a major signaling platform integrating various cellular functions. The fundamental, repeating unit of chromatin, the nucleosome, is composed of 146 base pairs of double-stranded DNA wrapped around an octameric protein complex made up of two copies of each of the core histones H2A, H2B, H3, and H4. Linear stretches of DNA packaged into nucleosomes are arranged into higher-order structures (e.g., the well-known appearance of mitotic chromosomes, Figure 1A) by additional proteins, RNA, and with the involvement of other molecules. Due to their composition and structure, nucleosomes bear pseudo-2-fold rotational symmetry with a so-called dyad symmetry axis (Figure 1B). All of the nucleosomes of a cell are essentially composed the same and have the same fundamental structure. A local difference between a given nucleosome and its neighbors besides the sequence and modification state of the wrapped DNA is brought about by (i) a plethora of posttranslational modifications (PTMs) that can occur on the histone proteins, (ii) the incorporation of histone variants, i.e., histone proteins that differ in primary amino acid sequence instead of the canonical histones, (iii) several mutations (i.e., single amino acid changes) of the histone proteins that have been linked to different types of cancer, and (iv) the establishment of subnucleosomal complexes that do not contain the canonical histone octamer.